Neuroscience
Stem Cell
72%
Glycosaminoglycan
58%
Heparan Sulfate
40%
Central Nervous System
38%
Lysosomes
36%
Neurodegeneration
33%
Genistein
23%
Neurotropism
23%
Randomized Controlled Trial
23%
Cell Therapy
23%
Macrophage
23%
Polyinosinic:polycytidylic Acid
23%
Actinomycin
23%
Acetylglucosaminidase
23%
Iduronate-2-Sulfatase
23%
Sanfilippo Syndrome
23%
Hunter Syndrome
23%
Blood Brain Barrier
20%
Gliosis
20%
Hematopoietic Stem Cell
18%
Behavior (Neuroscience)
16%
Anti-Inflammatory
15%
Cell Damage
15%
Aglycone
13%
TLR 4
11%
Cell Line
11%
Sulfatase
11%
Enzyme Replacement Therapy
10%
Placebo
9%
Lysosome Enzyme
7%
Working Memory
7%
Carbohydrates
7%
Synapsin II
7%
Amnesia
7%
NOD-like Receptor
7%
TLR 3
7%
Caspase 1
7%
N Sulfoglucosamine Sulfohydrolase
7%
Proinflammatory Cytokine
7%
Receptor Protein
7%
Genetic Variation
7%
Neural Stem Cell
7%
NeuN
7%
Adeno-Associated Virus
7%
Inflammasome
7%
Adaptive Immunity
7%
Hippocampus
7%
Prednisolone
5%
In Vitro
5%
Medicine and Dentistry
Stem Cell Gene Therapy
73%
Mucopolysaccharidosis
69%
Diseases
58%
Lysosomal Storage Disease
37%
Hematopoietic Stem Cell
35%
Neurodegeneration
29%
Drive
27%
Storage Disease
26%
Cell Interaction
23%
Macrophage
23%
Interleukin 1
23%
Brain Tumor
23%
Acetylglucosaminidase
23%
Interleukin 1 Receptor Blocking Agent
23%
Iduronate 2 Sulfatase
23%
Busulfan
23%
Hunter Syndrome
23%
Immunocompetent Cell
23%
Blood Brain Barrier
19%
Glioblastoma
19%
Chimera
19%
Heparan Sulfate
18%
Nonmyeloablative Conditioning
15%
Neuroinflammation
13%
Gliosis
12%
Conditioning
11%
Inflammatory Cytokine
11%
Central Nervous System
9%
Interleukin-1
9%
Polyinosinic Polycytidylic Acid
9%
Cytokine
9%
Lysosome
8%
Gene Therapy
6%
Cell Damage
6%
Enzyme Replacement Therapy
5%
Engraftment
5%
Prednisolone
5%
Neurologic Disease
5%
Transplantation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mucopolysaccharidosis
100%
Disease
55%
Mouse
45%
Lysosome Storage Disease
43%
Mouse Model
34%
Nerve Degeneration
29%
Adeno Associated Virus
26%
Inflammation
26%
Storage Disease
26%
Lentivirus Vector
25%
Heparan Sulfate
24%
Hunter Syndrome
23%
Enzyme Deficiency
23%
Sanfilippo Syndrome
23%
Iduronate 2 Sulfatase
23%
Genistein
23%
Acetylglucosaminidase
23%
Blood-Brain Barrier
17%
Biodistribution
14%
Neurologic Disease
14%
Aglycone
13%
Genotoxicity
11%
Glycosaminoglycan
11%
Polyinosinic Polycytidylic Acid
9%
Cytokine
9%
Gliosis
9%
Nucleotide Binding Oligomerization Domain Like Receptor
7%
NOD SCID Gamma Mouse
7%
Placebo
6%
Replacement Therapy
5%
Pharmacodynamics
5%
Cell Viability
5%
Prednisolone
5%